Abstract
The term “endocarditis” was used for the first time in 1835 by Jean-Baptiste Bouillaud in France for a disease that underwent endless development throughout the nineteenth century. Infective endocarditis (IE) discoveries were provided by the synthesis of clinical medicine, pathology, and, after the proof and acceptance of germ theory, with the use of microbiology. Numerous observations by several scientists associated valvular lesions, point of entry, circulating microorganisms, fever, and extra cardiac manifestations with IE. The first animal endocarditis model was developed in 1878 in Poland by Ottomar Rosenbach. Since the end of the nineteenth century until today, significant advances have been made in understanding the pathophysiology, diagnostic modalities, and therapeutic options of the disease. Incidence of IE varies widely, ranging from 1.5 to 11.6 cases per 100,000 person-years. However, the incidence is largely unknown from many parts of the world due to lack of representative data. Globally, IE was responsible for 35,900 thousand deaths in 1990, increasing to 48,300 in 2010. IE is traditionally linked to rheumatic and congenital heart diseases, prosthetic valves, and previous episodes of IE; however, other emerging risk factors, such as intravenous drug abuse, intracardiac devices, HIV infection, and hemodialysis have been identified, and are surpassing the traditional risk factors, particularly in industrialized countries. Epidemiological surveys from several countries have confirmed that the epidemiological profile of IE has changed substantially. Although the overall IE incidence has remained stable, Staphylococcus aureus is now the most common causative organism in most of the industrialized world. IE patients have also shifted towards having an increased mean age, due to a higher prevalence of prosthetic valves and other cardiac devices, and a decreasing prevalence of rheumatic heart disease. Moreover, the proportion of IE patients undergoing surgery has increased over time to reach approximately 50 %. Despite advances in medical knowledge, diagnostic modalities, antimicrobial therapy, and surgical procedures, mortality from IE continues to be high.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Contrepois A. Notes on the early history of infective endocarditis and the development of an experimental model. Clin Infect Dis. 1995;20(2):461–6.
Contrepois A. Towards a history of infective endocarditis. Med Hist. 1996;40(1):25–54.
Grinberg M, Solimene M. Historical aspects of infective endocarditis. Rev Assoc Med Bras. 2011;57(2):228–33.
Millar B, Moore J. Emerging issues in infective endocarditis. Emerg Infect Dis. 2004;10(6):1110–6.
Wallace A, Young W, Osterhout S. treatment of acute bacterial endocarditis by valve excision and replacement. Circulation. 1965;31:450–3.
Thuny F, Grisoli D, Cautela J, Riberi A, Raoult D, Habib G. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol. 2014;30(9):1046–57.
Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;369(8):785.
Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132(3):1025–35.
Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968–76.
Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2010;85(5):422–6.
Bin Abdulhak A, Baddour L, Erwin P, Hoen B, Chu V, Mensah G, et al. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart. 2014;9(1):131–43.
Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665. doi:10.1371/journal.pone.0082665.
Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc. 2009;140(10):1238–44.
Tleyjeh IM, Steckelberg JM. Changing epidemiology of infective endocarditis. Curr Infect Dis Rep. 2006;8(4):265–70.
Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005;293(24):3022–8.
Desimone D, Tleyjeh I, Correa de Sa DD, Anavekar N, Lahr B, Sohail M, Mayo Cardiovascular Infections Study Group, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126(1):60–4.
Melton L. History of the Rochester epidemiology project. Mayo Clin Proc. 1996;71(3):266–74.
Delahaye F, Goulet V, Lacassin F, Ecochard R, Selton-Suty C, Hoen B, et al. Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J. 1995;16(3):394–401.
Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75–81.
Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.
Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31(15):1890–7.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tleyjeh, I.M., Bin Abdulhak, A.A. (2016). Definition and Epidemiology of Infective Endocarditis. In: Habib, G. (eds) Infective Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-32432-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-32432-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32430-2
Online ISBN: 978-3-319-32432-6
eBook Packages: MedicineMedicine (R0)